News 15 mai 2024 Allegria Therapeutics raises 3.5 million dollars in seed financing round Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The biotech startup is develo...
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Aktuell 15 mai 2024 Allegria Therapeutics nimmt 3,5 Millionen Dollar in Seed-Runde ein Allegria Therapeutics hat eine Seed-Finanzierung von 3,5 Millionen Dollar durch den Gründungsinvestor Forty51 Ventures erhalten. Das Biotech-Star...
Fact Sheet 10 abr 2024 Find out more about opportunities for imported processed food in Indonesia The total market size of Indonesia’s imported processed food is estimated to reach 19.4 billion USD in 2024. The country offers increasing busine...
Factsheet 10 abr 2024 Erfahren Sie mehr über den Markt für verarbeitete Lebensmittel in Indonesien Der indonesische Markt für ausländische verarbeitete Lebensmittel wird 2024 geschätzte 19,4 Mrd. US-Dollar erreichen. Das Land bietet zunehmende ...
News 01 mar 2024 Idorsia enters collaboration with Viatris The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the de...
Fiches d’information 10 abr 2024 Opportunités dans l’importation d’aliments transformés en Indonésie Le marché des aliments transformés importés en Indonésie pèse environ 19,4 milliards USD. Le pays offre des opportunités commerciales croissantes...
Factsheet 10 abr 2024 Opportunità nell’importazione di alimenti trasformati in Indonesia Il mercato degli alimenti trasformati importati in Indonesia vale circa 19,4 miliardi di dollari. Il Paese offre crescenti opportunità commercial...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
Aktuell 01 mar 2024 Idorsia vereinbart Kooperation mit Viatris Das Biotech-Unternehmen Idorsia und der nordamerikanische Pharmakonzern Viatris arbeiten bei der Entwicklung zweier Phase 3-Medikamente von Ido...
News 13 dez 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
Actualités 19 out 2023 Nouveaux fonds pour le traitement de régénération tissulaire de Mimix Biotherapeutics La société biennoise Mimix Biotherapeutics a annoncé la clôture d’un important tour d’investissement, auquel ont participé des investisseurs euro...
News 25 abr 2024 Swiss biotech achieves record revenues in 2023 Swiss biotech companies generated record revenues of 7.3 billion Swiss francs in 2023, while capital investments rose 50 per cent year on year to...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 jul 2024–28 jul 2024 Nangang District Taiwan